Clinical Trial Update: ODYSSEY (PENTA 20) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posted results of ODYSSEY (PENTA 20), a Phase 2/3 study in HIV infection sponsored by the PENTA Foundation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: PENTA Foundation | Conditions: HIV Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-07-29